Viewing Study NCT06745492


Ignite Creation Date: 2025-12-24 @ 3:40 PM
Ignite Modification Date: 2026-01-01 @ 3:00 PM
Study NCT ID: NCT06745492
Status: COMPLETED
Last Update Posted: 2024-12-20
First Post: 2024-12-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Low-dose Neostigmine at TOF Ratio of 0.7 Improves Neuromuscular Recovery
Sponsor: Seoul National University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module